Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17453364

Download in:

View as

General Info

PMID
17453364